Statera BioPharma (FRA:7CB) Accounts Payable: €8.21 Mil (As of Sep. 2022)


FRA:7CB Statera BioPharma Inc FRA:7CB
20 GF Score
Price €2.61
View Full Analysis

What is Statera BioPharma Accounts Payable?

Statera BioPharma FRA:7CB 20 Accounts Payable is €8.21 Mil as of Sep. 2022. GuruFocus rates FRA:7CB with a GF Score™ of 20/100.

Statera BioPharma's Accounts Payable for the quarter that ended in Sep. 2022 was €8.21 Mil.

Statera BioPharma's quarterly Accounts Payable increased from Mar. 2022 (€6.12 Mil) to Jun. 2022 (€7.64 Mil) and increased from Jun. 2022 (€7.64 Mil) to Sep. 2022 (€8.21 Mil).

Statera BioPharma's annual Accounts Payable declined from Dec. 2019 (€2.17 Mil) to Dec. 2020 (€0.93 Mil) but then increased from Dec. 2020 (€0.93 Mil) to Dec. 2021 (€3.51 Mil).

Statera BioPharma Accounts Payable Related Terms

Statera BioPharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Accounts Payable Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Accounts Payable
2.17 0.93 3.51

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.71 3.51 6.12 7.64 8.21
FRA:7CB
20GF Score
Statera BioPharma Inc FRA:7CB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Statera BioPharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €8.21 Mil mean?
Statera BioPharma (FRA:7CB) has a Accounts Payable of €8.21 Mil as of Sep. 2022. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Accounts Payable too high?
Statera BioPharma's current Accounts Payable is €8.21 Mil. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Accounts Payable compare to NRBO and PALI?
Statera BioPharma's Accounts Payable of €8.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Accounts Payable is €8.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (FRA:7CB) has a current Accounts Payable of €8.21 Mil. The current Accounts Payable is €8.21 Mil. Statera BioPharma's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Statera BioPharma (FRA:7CB), the current Accounts Payable is €8.21 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
20GF Score

Get the complete analysis for FRA:7CB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price